Cal-Maine Foods, Inc. research snapshot
CALM AI stock analysis reads Cal-Maine Foods as the largest US egg company with a debt-free balance sheet, roughly $19.70 of net cash per share, and a strategic shift toward specialty eggs and prepared foods, but also as a commodity producer now facing historically low wholesale egg prices, a suspended dividend, and sharply lower earnings. At the August 3, 2026 data cutoff, CALM traded near $87.92 with a verified market capitalization near $4.13 billion, calculated as $87.92 times 46.92 million shares. Fiscal 2026 net sales fell 31.7% and net income fell 74.0%, with a fourth quarter net loss of $35.9 million. This page uses scenario ranges and source checks, not a certain stock price prediction, and is for informational use only.
Current price
$87.92
Market cap
$4.12 billion
AI score
48 / 100
Rating
Debt-free egg producer facing record-low egg prices, a suspended dividend, and an improving specialty and prepared foods mix
Trend status
Above 20, 50 and 200 day averages but below the 8 day average, with RSI near 53
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Cal-Maine is the largest US egg company with national distribution and a diversified portfolio that spans conventional eggs, specialty eggs, and prepared foods. The business generates strong cash flow when prices normalize but is exposed to extreme commodity swings, as shown by a fiscal 2026 fourth quarter loss when wholesale egg prices hit historically low inflation-adjusted levels. | Medium |
| Moat | The moat is scale and distribution based rather than durable pricing power. National supply agreements, brands such as Eggland Best and Land O Lakes, and vertical integration create real advantages, but eggs remain a commodity and industry supply expanded enough in fiscal 2026 to push prices to record lows. | Medium |
| Management | Management navigated the DOJ investigation to a settlement with no fines or penalties, maintained a debt-free balance sheet, repurchased shares, and is investing $54 million to expand prepared foods capacity. The controlling Adams family ownership remains a governance concentration risk, and the dividend was suspended under the variable policy after a cumulative loss of $35.9 million. | Medium |
| Financial trend | Fiscal 2026 net sales were $2.91 billion, down 31.7%, and net income was $316.68 million, down 74.0%, with diluted EPS of $6.63 versus $24.95. The fourth quarter produced a net loss of $35.88 million on record-low egg prices, while specialty volume rose 2.4% for the year and prepared foods grew to 8.4% of net sales. | High |
| Valuation | At $87.92, CALM trades near 13.3x trailing EPS of $6.63, 54.4x forward earnings, 1.41x sales, and 1.57x book value, with roughly $19.70 of net cash per share. The three-scenario framework produces a bearish area near $40 to $55, a base area near $85 to $100, and a bullish area near $115 to $135 over three years depending on egg price recovery and the specialty and prepared foods mix. | Medium |
| Technical trend | Price is above the 20, 50, and 200 day moving averages but below the 8 day average, with RSI near 53 and a positive MACD near 2.35. The stock is roughly 25% below its 52-week high of $117.45 and recovered about 19% from its 52-week low near $71.92. | Medium |
| Risk level | Main risks include record-low egg prices and industry oversupply, further avian flu outbreaks, a suspended dividend that may not resume quickly, concentrated family control, feed and input cost volatility, retail and food service customer concentration, and litigation or regulatory follow-on beyond the DOJ settlement. | Medium-high |
| AI confidence | High for reported results, balance sheet, dividend policy, and market cap math. Medium for forward scenarios and technical levels because egg prices and avian flu timing are inherently uncertain. | High data confidence |
| Investment certainty | Low to medium certainty. The page frames scenarios and monitoring rules, not a buy or sell instruction, because the earnings cycle is volatile even though the balance sheet is strong. | Low-medium |
CALM AI stock forecast
The CALM AI stock forecast uses scenarios around the $87.92 quote, fiscal 2026 EPS of $6.63, forward earnings near $1.62 implied by the 54.4x forward P/E, and a debt-free balance sheet. The three-year framework produced a bearish area near $40 to $55, a base area near $85 to $100, and a bullish area near $115 to $135. Actual outcomes depend heavily on egg price recovery, supply discipline, avian flu, the specialty and prepared foods mix, and when the dividend resumes.
$115 to $135
More likely if wholesale egg prices normalize above the cost of production as supply-demand balance improves, specialty and prepared foods grow toward 50% or more of net sales, the Eggland Best Northeast expansion adds volume, prepared foods capacity expands by over 60% through fiscal 2028, and the dividend resumes once cumulative profitability returns.
$85 to $100
More likely if egg prices recover to mid-cycle levels but stay below fiscal 2025 peaks, conventional volume holds near flat, specialty volume keeps growing, prepared foods keeps improving margins, and the stock trades near 13 to 15x normalized EPS of roughly $6.50 to $7.00. This is broadly consistent with the analyst price target range of $79 to $88.
$40 to $55
More likely if industry oversupply persists and egg prices stay near record lows through fiscal 2027, forward earnings stay depressed near the $1.50 to $2.00 level, the dividend remains suspended, another avian flu shock disrupts flocks, or the specialty and prepared foods mix shift is too slow to offset conventional egg pricing.
CALM AI technical analysis
CALM AI technical analysis as of the August 3, 2026 data cutoff shows a medium-term recovery that is now stalling against the short-term trend. Price near $87.92 sits above the 20 day SMA near $87.52, the 50 day SMA near $81.68, and the 200 day SMA near $82.49, but below the 8 day SMA near $89.58, so the immediate trend is mixed. RSI near 52 to 54 is neutral, MACD near 2.35 is still positive, and the stock trades roughly 25% below its 52-week high of $117.45.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $87.92 | Google Finance quote around 11:31 AM ET on August 3, 2026, with open near $88.41, high $90.10, and low $87.07. |
| Near resistance | $89.58 to $89.83 | The 8 day SMA near $89.58 and the upper Bollinger Band (25) near $89.83 form the first resistance zone. |
| Next resistance | $90 to $95 | Psychological resistance near $90, followed by the analyst target zone where Google Finance lists a $79 to $85 range and StockAnalysis lists an average target near $88. |
| Near support | $87.52 to $82.49 | The 20 day SMA near $87.52 is the first support, then the 50 day SMA near $81.68 and the 200 day SMA near $82.49 form a broader support band. |
| Deeper support | $75.32 to $71.92 | The lower Bollinger Band (100) near $75.32 and the 52-week low near $71.92 represent deeper support levels. |
| Momentum | RSI near 52 to 54, MACD +2.35 | Financhill lists RSI near 53.79 and StockAnalysis near 52.19, both neutral, while MACD near 2.35 remains positive. |
| Volume | Average volume near 1.01 million shares | Google Finance and StockAnalysis both list average volume near 1.0 to 1.04 million shares, useful for judging breakout quality. |
| Volatility | Beta 0.23 to 0.27 | The stock is low beta and about 25% below its $117.45 52-week high, reflecting both the earnings reset and the low-beta profile. |
| Invalidation | Close below $81.50 | A decisive close below the 50 day SMA near $81.68 would weaken the medium-term recovery and open the door toward the $75 to $72 zone. |
CALM AI trading strategy
The CALM AI trading strategy is a rules based research framework for a commodity egg producer with record-low egg prices, a suspended dividend, a debt-free balance sheet, and a shifting product mix. It is not personalized advice and should be paired with fresh egg price data, avian flu reports, quarterly results, dividend policy updates, position sizing, and a defined invalidation level.
Watch for CALM to reclaim and hold the $89.50 to $89.80 zone on volume above average, then extend toward $95 to $100. A sustained move would need evidence that wholesale egg prices are recovering and that conventional margins are stabilizing rather than still falling.
A close back below $87.50 or a fresh leg down in egg prices should invalidate the near-term trend setup.
If CALM pulls back toward the $82.50 to $81.70 moving average band while the debt-free balance sheet and cash per share stay intact, compare the pullback against egg price trends and the fiscal 2027 first quarter report before assuming support is durable.
Do not buy the dip without a maximum loss rule, because commodity egg stocks can gap down on egg price news, avian flu, regulatory updates, or earnings revisions.
Track Urner Barry wholesale egg prices, industry supply and flock data, avian flu outbreaks, quarterly revenue and margin trends by segment, prepared foods capacity milestones, dividend policy restoration, feed costs, share repurchases, and short interest near 12.7% of shares outstanding.
Reduce confidence if egg prices stay at record lows, forward earnings stay near $1.50 to $2.00, the dividend stays suspended, or the specialty and prepared foods mix shift slows.
Investment research summary
Cal-Maine produces, grades, packages, and distributes shell eggs and prepared egg-based foods across the US. Customers pay because eggs are a staple protein and Cal-Maine scale, national distribution, and long-standing grocery and food service relationships make it the default large-volume supplier.
The moat is scale and distribution based rather than pricing power. National supply agreements, brands such as Eggland Best and Land O Lakes, vertical integration, and prepared foods capacity create real advantages, but eggs are a commodity and industry supply pushed wholesale prices to historically low levels in fiscal 2026.
The thesis fails if industry oversupply keeps egg prices at record lows, the dividend stays suspended for an extended period, another avian flu shock hits flocks, the specialty and prepared foods mix shift is too slow, or the Adams family controlling interest leads to capital allocation or governance decisions that hurt minority shareholders.
Management should be judged by capital allocation through the cycle, including the $54 million prepared foods expansion, the Van brand acquisition, share repurchases, dividend discipline under the variable policy, transparency with minority shareholders given family control, and how they execute after the DOJ settlement with no fines or penalties.
Egg consumption remains a stable staple, but the industry faces cage-free transition, recurring avian flu, oversupply cycles, and consumer preference shifts. Cal-Maine is positioning for these trends by expanding specialty eggs and prepared foods, which grew to 44.4% of net sales in fiscal 2026.
At near 13.3x trailing EPS and 54.4x forward earnings, CALM looks cheap on trailing earnings but expensive on the depressed forward base, with roughly $19.70 of net cash per share as a cushion. Margin of safety depends on whether egg prices recover toward mid-cycle levels and whether the mix shift lifts the earnings floor, or whether the current low prices persist.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| CALM price | $87.92 | Google Finance quote snapshot | August 3, 2026 |
| Market capitalization | $4.12 billion, verified as $87.92 x 46.92 million shares = $4.13 billion | Google Finance, verified by financial_rigor.py market cap check | August 3, 2026 |
| Shares outstanding | 46.92 million | Google Finance and StockAnalysis | August 3, 2026 |
| Fiscal 2026 net sales | $2.91 billion, down 31.7% from $4.26 billion | Cal-Maine Foods Q4 fiscal 2026 earnings release | July 22, 2026 |
| Fiscal 2026 net income | $316.68 million, down 74.0%, diluted EPS $6.63 versus $24.95 | Cal-Maine Foods Q4 fiscal 2026 earnings release | July 22, 2026 |
| Q4 fiscal 2026 result | Net sales $552.58 million, net loss $35.88 million, EPS -$0.76 | Cal-Maine Foods Q4 fiscal 2026 earnings release | July 22, 2026 |
| P/E ratio | 13.22 trailing, 54.36 forward | StockAnalysis statistics | August 3, 2026 |
| Balance sheet | $924.06 million cash, zero debt, net cash $19.70 per share, book value $56.04 per share | StockAnalysis statistics | August 3, 2026 |
| Dividend policy | Trailing dividend $4.81 (5.49% yield) but Q4 dividend suspended; no dividend until cumulative profitability restored, current cumulative loss $35.9 million | Cal-Maine Foods Q4 fiscal 2026 earnings release | July 22, 2026 |
| DOJ resolution | No fines or penalties; compliance measures, donation of 30 million eggs, and $1.5 million paid to states | Cal-Maine Foods DOJ resolution press release | June 29, 2026 |
| Technical snapshot | 8-day SMA 89.58, 20-day SMA 87.52, 50-day SMA 81.68, 200-day SMA 82.49, RSI 53.79, MACD 2.35 | Financhill technical analysis snapshot | July 30, 2026 |
| Analyst consensus | Hold consensus; Google Finance average target $82.33, StockAnalysis average target $88.00 | Google Finance and StockAnalysis analyst ratings | August 3, 2026 |
This page is an informational research tool only and is not investment advice, financial advice, or a recommendation to buy or sell CALM stock. Forecast scenarios are based on available public data, technical snapshots, and stated assumptions as of the data cutoff date and may be wrong. Egg prices, avian flu, supply conditions, dividend policy, and regulatory outcomes can change quickly. Always verify current filings, prices, risks, and personal suitability before making financial decisions.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
